Revival Research Institute, LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Atopic dermatitis (eczema)1 trial
• Hidradenitis suppurativa1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Pfizer1 trial
• Shaperon1 trial

Running trials

• Recruiting

  A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  NCT07602582· Phase 3· Eli Lilly and Company· Source

  Contact: Abdulhassan Saad (principal investigator)

• Active, not recruiting

  A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

  NCT07228390· Phase 2· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting

Closed trials

• Completed

  Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

  NCT06024499· Phase 2· Shaperon· Source